Track your comments!
[x]


When you register, comments on your articles and replies to your comments appear here. Register Now!

Sign in to your account
[x]

Not a Scientific Blogging member yet?

Register Now for a Free Scientificblogging.com Account

  • Customize your profile with pictures, banner, a blogroll and more.
  • Leave comments on articles, add other members to your friend lists, chat with people on the site.
  • Write blog posts that can be seen by hundreds of thousands of readers.

It's free and it only takes a minute!

Already a Scientific Blogging member?

Sign In Now

Banner
By Michael White | January 6th 2009 12:31 PM | Print | E-mail | Track Comments

More Adaptive Complexity articles

All

About Michael White

Welcome to Adaptive Complexity, where I write about genomics, systems biology, evolution, and the connection between science and literature, government, and society.

I'm a biochemist


... Full Bio

John Hawks discusses how messy the abuse of genetic testing results could get:

Imagine a custody battle, in which the father hires a private investigator to get a mother's genome. With two variants that yield a 15 percent higher risk of schizophrenia, will the mother's genetic risk be held against her? Or think of corporate boards, looking for a way to dismiss a CEO without paying that golden parachute. Could a genetic test result showing a higher risk for early Alzheimer's give them a reason to invoke a "health" clause in the contract?

Or what about, Hawks asks, "a sitting President, whose public genome data show a newfound association with a personality disorder?"

I once wrote that I thought there should be no regulations against getting yourself genotyped, but that the medical interpretation of that genotype by companies like 23andMe should be governed by the same standards as any other diagnostic test. That won't prevent scenarios like this from happening, where personal genome data is obtained and made public involuntarily. These scenarios would be bad enough if we started making such judgments even if our risk estimates were very good. What makes them potentially so much worse is that we don't have great risk estimates yet.

As Hawks points out (and as I wrote about here), the studies our risk predictions are based on focus on the effects of single gene variants, and don't do a good job of taking into account the impact of combinations of genetic variants. You may have one variant of one gene associated with a risk for heart disease, but the effects of that variant may be modified by variants in other genes that reduce your risk for heart disease. If we don't know how these different variants act in combination, we can't make accurate risk assessments on an individual level, even though we may be able to talk about average effects of a genetic variant in a population.

Our society doesn't always do a great job of keeping junk science out of major decisions in policy or law, and the wide public availability of personalized genetic information has the potential for producing disruptive junk science on a massive scale. This may call for extremely strict privacy laws, with hefty penalties for 'genomic eavesdropping', and tight regulation on how such information can be used in court. Even with such regulations, I predict that we'll see a Supreme Court case on genetic privacy within the next 15 years.

Add a comment

The content of this field is kept private and will not be shown publicly.
  • Allowed HTML tags: <sup> <sub> <a> <em> <strong> <center> <cite> <code> <TH><ul> <ol> <li> <dl> <dt> <dd> <img> <br> <p> <blockquote> <strike> <object> <param> <embed> <del> <pre> <b> <i> <table> <tbody> <div> <tr> <td> <h1> <h2> <h3> <h4> <h5> <h6> <hr> <iframe>
  • Lines and paragraphs break automatically.
  • Web page addresses and e-mail addresses turn into links automatically.
CAPTCHA
If you register, you will never be bothered to prove you are human again.
Image CAPTCHA
Copy the characters (respecting upper/lower case) from the image.